• 1
    Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base Report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951962.
  • 2
    Eisbruch A, Ship JA, Martel MK. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys 1996;36:469480.
  • 3
    Chao KSC, Low D, Perez CA, Purdy JA. Intensity modulated radiation therapy in head and neck cancers: the Mallinckrodt experience. Radiat Oncol Invest 2000;90:92103.
  • 4
    Verellen D, Linthout N, van den Berg D, Bel A, Storme G. Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. Int J Radiat Oncol Biol Phys 1997;39:99114.
  • 5
    DeNeve W, DeGersem W, Derycke S. Clinical delivery of intensity modulated conformal radiotherapy for relapsed or second-primary head and neck cancer using a multileaf collimator with dynamic control. Radiother Oncol 1999;50:301314.
  • 6
    Meeks SL, Buatti JM, Bova FJ, Friedman WA, Mendenhall WM, Zlotecki RA. Potential clinical efficacy of intensity-modulated conformal therapy. Int J Radiat Oncol Biol Phys 1998;40:483495.
  • 7
    Ho JHC. An epidemiological and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4:183197.
  • 8
    Wang DC, Cai WM, Hu YH, Gy XZ. Long-term survival of 1035 cases of nasopharyngeal carcinoma. Cancer 1988;61:23382341.
  • 9
    Marcial VA, Hanley JA, Chang C, Davis LW, Moscol JA. Split-course radiation therapy of carcinoma of the nasopharynx: results of a national collaborative clinical trial of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:409414.
  • 10
    Al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovic A, Ager PJ. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a Radiation Therapy Oncology Group study. J Clin Oncol 1990;8:13421351.
  • 11
    Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:13101317.
  • 12
    van den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol 2000;33:230238.
  • 13
    Valdez IH. Radiation induced salivary dysfunction. Clinical course of significance. Spec Care Dentist 1991;11:252255.
  • 14
    Mossman K, Shatzman A, Chencharick J. Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys 1982;8:991997.
  • 15
    Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:847856.
  • 16
    Ship JA, Fox PC, Baum BJ. How much saliva is enough? Normal function defined. J Am Dent Assoc 1991;122:6369.
  • 17
    Johnson JT, Ferretti GA, Nethery WJ. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390395.
  • 18
    Jha N, Seikaly H, McGaw T, Coulter L. Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 2000;46:711.
  • 19
    Butler EB, Teh BS, Grant WHr. SMART (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:2132.
  • 20
    Chao C, Cheng J, Low D, Purdy J, Perez C. Intensity modulated radiation therapy provides better tumor target coverage and normal tissue sparing in patients with nasopharyngeal carcinoma (abstract). Int J Radiat Oncol Biol Phys 1999;45:420.
  • 21
    Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46:195205.
  • 22
    Reinstein LE, Wang X-H, Burman CM. A feasibility study of automated inverse treatment planning for cancer of the prostate. Int J Radiat Oncol Biol Phys 1998;40:207214.
  • 23
    Chao KSC, Deasy JO, Markman J. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907916.
  • 24
    Mira JG, Westcott WB, Starcke EN, Shannon JL. Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys 1981;7:535541.
  • 25
    Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol 1999;9:7898.
  • 26
    Goitein M, Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. Int J Radiat Oncol Biol Phys 1996;36:519522.